U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Newsroom
  4. FDA In Brief
  5. FDA In Brief: FDA Seeks Input from the Public to Help Prevent Future Lung Injuries Associated with Vaping
  1. FDA In Brief

FDA In Brief: FDA Seeks Input from the Public to Help Prevent Future Lung Injuries Associated with Vaping

February 14, 2020

Media Inquiries

  Stephanie Caccomo
  301-348-1956

The following quote is attributed to FDA Commissioner Stephen M. Hahn, M.D:

“Since last year, the Food and Drug Administration, the Centers for Disease Control and Prevention and state health authorities have diligently worked to identify substances of concern and characterize the outbreak of lung injuries associated with vaping products.

“We remain deeply concerned about these injuries and deaths and continue to work with other agencies, as well as state and local public health officials, on this complex investigation. National and state data from patient reports and product sample testing suggest vaping products containing tetrahydrocannabinol, particularly from informal sources like friends, or family, or in-person or online dealers, are linked to most cases and play a major role, and that the presence of the compound vitamin E acetate in vaping products is strongly linked to the outbreak.

“Our investigation has brought to the forefront the serious risks of using illicit, black market products. As part of our efforts to mitigate and prevent a potential future outbreak of vaping injuries, we are asking the public for input on additional steps the FDA can take to inform our regulatory work and address the illegal modification of these products.”

  • Today, the U.S. Food and Drug Administration opened a docket to obtain data and information related to the use of vaping products that are associated with e-cigarette, or vaping, product use-associated lung injury (EVALI).
  • This request for information responds to direction from Congress to gather information from the public that could help identify and evaluate additional steps the FDA could take to address the recent lung injuries associated with the use of vaping products and to help prevent similar occurrences in the future.
  • The FDA is seeking unpublished data or information related to the use of vaping products that are associated with recent lung injuries including information on specific chemicals, compounds, ingredients or combinations of ingredients that when inhaled or aerosolized, may be associated with EVALI symptoms, as well as product design and potential ways to prevent consumers from modifying or adding substances to these products that are not intended by the manufacturers.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

 

 
Back to Top